• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: INSULET CORPORATION OMNIPOD DASH INSULIN MANAGEMENT SYSTEM; PUMP, INFUSION, INSULIN

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

INSULET CORPORATION OMNIPOD DASH INSULIN MANAGEMENT SYSTEM; PUMP, INFUSION, INSULIN Back to Search Results
Model Number 18320
Device Problem Insufficient Information (3190)
Patient Problems Hyperglycemia (1905); Renal Failure (2041); Diabetic Ketoacidosis (2364); Coma (2417); Loss of consciousness (2418); Respiratory Failure (2484)
Event Date 06/23/2020
Event Type  Injury  
Manufacturer Narrative
The device has not been returned/received to date.If received a supplemental report will be submitted with the investigation results.We are unable to determine if any product condition could have contributed to the reported hospitalization and diabetic ketoacidosis.Lot release records were reviewed and the product lot met all acceptance criteria.For your reference, insulet modified our internal investigation finding codes effective 25 may 2020 as part of an effort to improve the classification of findings to improve the power of trending data and make the findings more intuitive.The new findings codes will use the system of finding category (e.G.Hardware component), followed by the affected component (e.G.Needle), followed by the condition (e.G.Bent).Therefore you may notice findings that appear to be new or different but in fact are just renamed for improved data value.Insulet would be happy to explain any mapping of the old to new finding codes if you have any questions.
 
Event Description
It was reported that a patient went to the emergency room (er) by ambulance and was diagnosed with diabetic ketoacidosis (dka).The patient's blood glucose values reached over 1000 mg/dl.The patient was reported to be in a coma, when found at home.For treatment, the patient was put on dialysis for kidney failure, put on a ventilator, and given insulin at 40 units a day.The daughter stated that the history showed a pod was not worn close to 24 hours.The patient had blood work conducted on them and was admitted to the intensive care unit (icu).
 
Manufacturer Narrative
Data downloaded from the device indicates an 0x6a occlusion alarm occurred during the run.Physical inspection found no damages or defects that would contribute to an occlusion.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
OMNIPOD DASH INSULIN MANAGEMENT SYSTEM
Type of Device
PUMP, INFUSION, INSULIN
Manufacturer (Section D)
INSULET CORPORATION
100 nagog park
acton MA 01720
MDR Report Key10241915
MDR Text Key197969981
Report Number3004464228-2020-10866
Device Sequence Number1
Product Code LZG
UDI-Device Identifier20385082000020
UDI-Public(01)20385082000020(11)190503(17)201103(10)PD1C05031921
Combination Product (y/n)N
PMA/PMN Number
K192659
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type consumer
Type of Report Initial,Followup
Report Date 06/25/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Device Expiration Date11/03/2020
Device Model Number18320
Device Catalogue NumberBLE-I1-529
Device Lot NumberPD1C05031921
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer08/10/2020
Initial Date Manufacturer Received 06/25/2020
Initial Date FDA Received07/07/2020
Supplement Dates Manufacturer Received08/17/2020
Supplement Dates FDA Received08/27/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age60 YR
-
-